Home › Peripheral Arterial Disease › Minnesota
Peripheral Arterial Disease clinical trials in Minnesota
9 studies for Peripheral Arterial Disease are looking for participants at sites in Minnesota.
Cities in Minnesota
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DCR Edina, Minneapolis
- Minneapolis VA Health Care System, Minneapolis
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Community-based Exercise Following Revascularization for PAD
- University of Minnesota, Minneapolis
Recruiting
Ages 40 to 90 · All sexes · Updated Sep 9, 2026 · NCT04252950The COCOA-PAD II Trial
- University of Minnesota, Minneapolis
RecruitingPhase 3
Ages 55 and older · All sexes · Updated May 28, 2026 · NCT04794530Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
- Mayo Clinic in Rochester, Rochester
RecruitingHealthy volunteers welcome
Ages 18 to 75 · All sexes · Updated May 5, 2026 · NCT06952543BEETroot Juice to Reverse Functional Impairment in PAD
- University of Minnesota, Minneapolis
Recruiting
Ages 50 and older · All sexes · Updated Apr 15, 2026 · NCT05624125SMART Exercise for PAD
- University of Minnesota, Minneapolis
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 15, 2026 · NCT06032065Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Mayo Clinic, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT04774159Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Jan 14, 2026 · NCT06308562Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.